| Sources | Names Used |
|---|---|
| CTRPv2 | 1S,3R-RSL-3 |
| PharmacoGx | 1S,3R-RSL-3 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QDPR | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SLC27A5 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | MRPS11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | LRRC43 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | MYT1L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | RP11-162P23.2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SPPL2A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | NPEPL1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ZNF71 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ZNF358 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
